摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

trans-[PtCl2(N=C(Me)O-N(Me)-C(H)Ph)2] | 324764-91-2

中文名称
——
中文别名
——
英文名称
trans-[PtCl2(N=C(Me)O-N(Me)-C(H)Ph)2]
英文别名
(3R)-2,5-dimethyl-3-phenyl-3H-1,2,4-oxadiazole;platinum(2+);dichloride
trans-[PtCl2(N=C(Me)O-N(Me)-C(H)Ph)2]化学式
CAS
324764-91-2
化学式
C20H24Cl2N4O2Pt
mdl
——
分子量
618.422
InChiKey
KRHHXFMJMOBKLP-FWPCSCPESA-L
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -2.03
  • 重原子数:
    29
  • 可旋转键数:
    2
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    49.7
  • 氢给体数:
    0
  • 氢受体数:
    8

反应信息

  • 作为反应物:
    描述:
    trans-[PtCl2(N=C(Me)O-N(Me)-C(H)Ph)2]氘代氯仿 为溶剂, 以99%的产率得到trans-[PtCl4(N=C(Me)O-N(Me)-C(H)(Ph))2]
    参考文献:
    名称:
    [2 + 3] Cycloaddition of Nitrones to Platinum-Bound Organonitriles:  Effect of Metal Oxidation State and of Nitrile Substituent
    摘要:
    The ligated benzonitriles in the platinum(II) complex [PtCl2(PhCN)(2)] undergo metal-mediated [2+3] cycloaddition with nitrones -ON+(R-3)=C(R-1)(R-2) [R-1/R-2/R-3 = H/Ph/Me, H/p-MeC6H4/Me, H/Ph/CH2Ph] to give Delta (4)-1,2,4-oxadiazoline complexes, [PtCl2{N=C(Ph)O-N(R-3)-C(R-1)(R-2)}(2)] (2a, 4a, 6a), as a 1:1 mixture of two diastereoisomers, in 60-75%, while [PtCl2(MeCN)(2)] is inactive toward the addition. However, a strong activation of acetonitrile was reached by application of the platinum(IV) complex [PtCl4(MeCN)(2)] and both [PtCl4(RCN)(2)] (R = Me, Ph) react smoothly with various nitrones to give [PtCl4{N=C(R)O-N(R-3)-C(R-1)(R-2)}(2)] (1b-6b). The latter were reduced to the corresponding platinum(II) complexes [PtCl2{N=C(R)O-N(R-3)-C(R-1)(R-2)}(2)] (1a-6a) exhibit different kinetic labilities, and liberation of the Delta (4)-1,2,4-oxadiazolines by substitution with 1,2-bis(diphenylphosphino)ethane (dppe) in CDCl3 proceeds at different rates to give free N=C(R)O-N(R-3)-C(R-1)(R-2) and [PtCl2(dppe)] in almost quantitative NMR yield. All prepared compounds were characterized by elemental analyses, FAB mass spectrometry, and IR and H-1, C-13{H-1}, and 195 Pt (metal complexes) NMR spectroscopies; X-ray structure determination of the first (Delta (4)-1,2,4-oxadiazoline)Pt(II) complexes was performed for (S,S)/(R,R)-rac-[PtCl2{N=C(Me)O-C(H)Ph-2}(2)] (1a) (a = 9.3562(4), b = 9.8046(3), c = 13.1146(5) Angstrom; alpha = 76.155(2), beta = 83.421(2), gamma = 73.285(2)degrees; V = 1117.39(7) Angstrom (3); triclinic P (1) over bar, Z = 2), (R,S)-meso-[PtCl2-(N=C(Ph)O-N(Me)-C(H)Ph)(2)] (2a) (a = 8.9689(9), b = 9.1365(5), c = 10.1846(10) Angstrom; alpha = 64.328(6), beta = 72.532(4), gamma = 67.744(6)degrees; V = 686.82(11) Angstrom (3); triclinic, P (1) over bar, Z = 1), (S,S)/(R,R)-rac-[PtCl2(N=C(Me)O-N(Me)-C(H)(p-C6H4Me))(2)] (3a) (a = 11.6378(2), b = 19.0767(7), c = 11.5782(40 Angstrom; beta = 111.062(2)degrees; V = 2398(13) Angstrom (3); monoclinic, P2(1)/c, Z = 4), and (S,S)/(R,R)-rac-[PtCl2(N=C(Me)O-N(CH2Ph)-C(H)Ph)-C(H)Ph-2] (5a) (a = 10.664(2), b = 10.879(2), c = 14.388(3) Angstrom; alpha = 73.11(3), beta = 78.30(3), gamma = 88.88(30 degrees; V = 1562.6(6) Angstrom (3); triclinic, P (1) over bar, Z = 2).
    DOI:
    10.1021/ic000477b
  • 作为产物:
    描述:
    trans-[PtCl4(N=C(Me)O-N(Me)-C(H)(Ph))2] 在 C6H5CH2NHOH*HCl 、 NaHCO3 、 H2O 作用下, 以 二氯甲烷 为溶剂, 以56%的产率得到trans-[PtCl2(N=C(Me)O-N(Me)-C(H)Ph)2]
    参考文献:
    名称:
    [2 + 3] Cycloaddition of Nitrones to Platinum-Bound Organonitriles:  Effect of Metal Oxidation State and of Nitrile Substituent
    摘要:
    The ligated benzonitriles in the platinum(II) complex [PtCl2(PhCN)(2)] undergo metal-mediated [2+3] cycloaddition with nitrones -ON+(R-3)=C(R-1)(R-2) [R-1/R-2/R-3 = H/Ph/Me, H/p-MeC6H4/Me, H/Ph/CH2Ph] to give Delta (4)-1,2,4-oxadiazoline complexes, [PtCl2{N=C(Ph)O-N(R-3)-C(R-1)(R-2)}(2)] (2a, 4a, 6a), as a 1:1 mixture of two diastereoisomers, in 60-75%, while [PtCl2(MeCN)(2)] is inactive toward the addition. However, a strong activation of acetonitrile was reached by application of the platinum(IV) complex [PtCl4(MeCN)(2)] and both [PtCl4(RCN)(2)] (R = Me, Ph) react smoothly with various nitrones to give [PtCl4{N=C(R)O-N(R-3)-C(R-1)(R-2)}(2)] (1b-6b). The latter were reduced to the corresponding platinum(II) complexes [PtCl2{N=C(R)O-N(R-3)-C(R-1)(R-2)}(2)] (1a-6a) exhibit different kinetic labilities, and liberation of the Delta (4)-1,2,4-oxadiazolines by substitution with 1,2-bis(diphenylphosphino)ethane (dppe) in CDCl3 proceeds at different rates to give free N=C(R)O-N(R-3)-C(R-1)(R-2) and [PtCl2(dppe)] in almost quantitative NMR yield. All prepared compounds were characterized by elemental analyses, FAB mass spectrometry, and IR and H-1, C-13{H-1}, and 195 Pt (metal complexes) NMR spectroscopies; X-ray structure determination of the first (Delta (4)-1,2,4-oxadiazoline)Pt(II) complexes was performed for (S,S)/(R,R)-rac-[PtCl2{N=C(Me)O-C(H)Ph-2}(2)] (1a) (a = 9.3562(4), b = 9.8046(3), c = 13.1146(5) Angstrom; alpha = 76.155(2), beta = 83.421(2), gamma = 73.285(2)degrees; V = 1117.39(7) Angstrom (3); triclinic P (1) over bar, Z = 2), (R,S)-meso-[PtCl2-(N=C(Ph)O-N(Me)-C(H)Ph)(2)] (2a) (a = 8.9689(9), b = 9.1365(5), c = 10.1846(10) Angstrom; alpha = 64.328(6), beta = 72.532(4), gamma = 67.744(6)degrees; V = 686.82(11) Angstrom (3); triclinic, P (1) over bar, Z = 1), (S,S)/(R,R)-rac-[PtCl2(N=C(Me)O-N(Me)-C(H)(p-C6H4Me))(2)] (3a) (a = 11.6378(2), b = 19.0767(7), c = 11.5782(40 Angstrom; beta = 111.062(2)degrees; V = 2398(13) Angstrom (3); monoclinic, P2(1)/c, Z = 4), and (S,S)/(R,R)-rac-[PtCl2(N=C(Me)O-N(CH2Ph)-C(H)Ph)-C(H)Ph-2] (5a) (a = 10.664(2), b = 10.879(2), c = 14.388(3) Angstrom; alpha = 73.11(3), beta = 78.30(3), gamma = 88.88(30 degrees; V = 1562.6(6) Angstrom (3); triclinic, P (1) over bar, Z = 2).
    DOI:
    10.1021/ic000477b
点击查看最新优质反应信息

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫